Novocure Ltd.

( )
NVCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
DXCMDexCom, Inc. 1.47%405.258.2%$1125.17m
ABTAbbott Laboratories 1.21%91.480.8%$665.73m
BDXBecton, Dickinson & Co. 0.02%238.991.0%$578.24m
DHRDanaher Corp. 0.38%158.260.7%$553.32m
INOInovio Pharmaceuticals, Inc. -1.12%14.086.3%$535.38m
TMOThermo Fisher Scientific, Inc. 1.33%340.211.0%$518.96m
MDTMedtronic Plc -0.72%94.720.6%$496.22m
BSXBoston Scientific Corp. 3.25%35.921.1%$390.41m
ISRGIntuitive Surgical, Inc. 3.09%562.802.4%$339.49m
SYKStryker Corp. -0.49%184.181.3%$328.26m
ALGNAlign Technology, Inc. 3.30%243.746.4%$308.63m
WSTWest Pharmaceutical Services, Inc. 0.28%211.621.6%$286.75m
BAXBaxter International, Inc. 0.43%86.931.8%$226.10m
EWEdwards Lifesciences Corp. 0.17%218.871.2%$211.02m
QDELQuidel Corp. -3.99%173.497.7%$204.62m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.